~" A prospective longitudinal evaluation of serum zinc concentrations was performed in 26 head-trauma patients, and 24-hour urine zinc excretion was determined in 15 of these subjects. Patients had markedly depressed admission serum zinc concentrations (mean -+ standard error of the mean: 40.2 + 3.2 ug/dl; normal values: 70 to 120 #g/dl), which gradually increased during the 16-day study period. All subjects demonstrated increased urinary zinc losses throughout the study period. Urinary zinc excretion was greater in patients with more severe head injuries. Indeed, patients with more severe head trauma had mean peak urinary zinc losses of greater than 7000 ug/day (normal less than 500 (ug/day). The implications of this altered zinc metabolism for protein metabolism, wound healing, and immune function, and the specific role of zinc in brain function and recovery from injury are discussed.
Patient Population
The subjects consisted of 26 consecutive head-injured patients whose peak admission Glasgow Coma Scale (GCS) scores within 24 hours of injury were 4 to 10 ( Table 1) . Ages ranged from 18 to 74 years, with a mean age of 29.9 years. Although nine patients had injuries to several systems, the most severe injury in each case was to the brain. Twenty were male and six female. All were admitted to the University of Kentucky Medical Center Intensive Care Unit, 12 required craniotomy, and all required mechanical ventilation. Patients were randomly assigned on admission to receive either enteral or parenteral support. Enteral feedings were started when bowel sounds were present and CHI  7  no  no  severely disabled  22  28, M  GSW  7  yes  no  vegetative  23  51, M  CHI  8  no  no  severely disabled  24  27, M  CHI, femoral fx  9  no  yes  vegetative  25  40, M  GSW  8  yes  yes  died  26 24, M CHI, liver capsule laceration 5 yes yes died * CHI = closed-head injury; fx = fracture; GSW = gunsho', wound. i" Peak admission Glasgow Coma Scale (GCS) 58 score within 24 hours of trauma.
gastric residual volumes were less than 100 cc/hr. The enteral feeding formulas used were TraumaCal or Ensure Plus.* An enteral feeding pump was used which allowed continuous formula administration, and feeding tubes were placed in the small intestine in 50% of enterally fed patients. Metoclopramide was used when gastroparesis was evident. Feedings were initiated at one-quarter strength, 25 cc/hr, with the concentration or rate increased every 4 to 6 hours as tolerated. If enteral feedings were not tolerated by Day 7, parenteral support was instituted. Parenteral feedings consisted of sterile amino acid/dextrose solutions and intravenous lipid emulsions. These patients received 17% of total kilocalories (kcal) as protein, 41% as fat, and 42% as dextrose. Parenteral support was initiated at 25 cc/hr then increased every 6 hours until the desired rate was achieved. Caloric requirements were assessed by calculating the patient's resting energy expenditure (REE) with the Harris-Benedict equation and multiplying by an activity factor of 1.75. Mannitol, an osmotic agent, was given * Enteral feeding formula, TraumaCal, made by Mead Johnson Nutrition Division, Evansville, Illinois, and Ensure Plus made by Ross Laboratories, Columbus, Ohio. to 14 patients. Dexamethasone, known to depress serum zinc levels, was not given to patients after they were admitted to our institution. Daily assessment of patients' level of consciousness was made, based on the GCS. 58 On Day 18, all patients were grouped according to the Glasgow Outcome Scale: 33 seven patients had died, seven were vegetative, eight were severely disabled, three were moderately disabled, and one had good recovery.
Zinc Analysis
Serum samples for zinc analysis were drawn on Days l, 4, 7, 10, 13, and 16 in all patients. Blood samples were drawn between 8:00 and 10:00 a.m. in zinc-free plastic syringes. Fifteen patients had 24-hour urine specimens collected for zinc and creatinine analysis on the day of their serum zinc determination. Urine samples were collected in metal-free plastic jugs. All samples were handled in a manner to avoid external zinc contamination and were frozen in zinc-free plastic tubes until analyzed. Specimens were then diluted and zinc was measured by flame atomic absorption spectrophotometry using a Varian Techtron AA375t as described t Varian Techtron, Model AA375, manufactured by Varian Associates, Palo Alto, California. by us previously. 43 '44 Creatinine levels were measured by the hospital clinic laboratory.
C-Reactive Protein
C-reactive protein, a nonspecific marker for the acute phase response, was determined in patients on Days 1, 4, 7, 10, 13, and 16. This test was used as an indicator of "stress" in these subjects24 C-reactive protein was analyzed by radial immunodiffusion using commercially available kits.z~
Calorie and Protein Intake
Daily calorie and protein intake for nasoenteric or intravenous feeding were carefully recorded. Calculations for nasoenteric feedings were made according to the manufacturer's information. Intravenous administration was calculated using the following factors: 1 gm amino acid = 4 kcal, 1 gm dextrose = 3.4 kcal, and fat emulsions from the manufacturer's information.
Nitrogen Balance
Nitrogen balance was calculated by the following formula: N2 (gm) -[urinary urea N2 (gm) + insensible loss (4 gm)]. 7
Results
Serum zinc levels were lowest on Day 1 post-injury, with a mean level (_+ standard error of the mean) of 40.2 _+ 3.2 #g/dl (normal 70 to 120 #g/dl). Mean serum zinc levels gradually increased over the course of hospitalization, but still had not returned to normal by the end of the study (Fig. 1) . Although there was a trend for a greater depression in the serum zinc concentration at admission in patients with an unfavorable compared to a favorable outcome (38.1 _+ 3.5 vs 51.3 + 8.1 #g/ dl), this difference was not significant, possibly because of the small number of patients (four) in the favorable outcome category. There was no significant difference in the serum zinc concentrations between the group receiving enteral and that receiving parenteral nutrition, despite the fact that the parenteral group was given more calories and protein for the first 7 days post-injury than the enteral group (Tables 2 and 3) .
Urinary zinc levels were modestly elevated on Day 1, but rose dramatically during hospitalization (Fig. 2) . The patients with the most severe head injury (low admission GCS score) had the most severe urinary zinc loss (p < 0.1) ( Table 4) . 64 The 24-hour urinary excretion of creatinine decreased toward the end of the study, presumably reflecting loss of muscle mass in these catabolic patients. Urinary zinc excretion remained elevated, however; possibly reflecting continued muscle catabolism with release of zinc from muscle. Thus, the molar ratio of zinc to creatinine in the urine increased in the later phase of the study, and zinc excretion did :~ Radial immunodiffusion kit manufactured by Calbio. chem-Behring Corp., La Jolla, California. not parallel creatinine excretion (Table 3) . Peak zinc intake for any one study day was approximately 4.5 mg in parenterally treated subjects and 23 mg in patients receiving enteral nutritional support. While intravenous zinc intake was relatively stable, oral zinc intake varied greatly depending on ability to tolerate oral feedings (data not shown). Caloric and protein intake was initially depressed in these patients and increased throughout the duration of the hospital course ( Table 3 ). The initial low intake of protein and calories mainly reflected the inability of the patients fed enterally to tolerate oral products because of gastroparesis. As expected, nitrogen balance was initially markedly negative. Indeed, nitrogen balance stayed negative throughout the hospital course, even in the face of high protein and caloric intake at the end of hospitalization (Table  3) . C-reactive protein levels were markedly elevated upon admission, peaked at approximately 4 days after injury, and then gradually declined over the course of the study (Fig. 3) . 
Discussion
Serum zinc concentrations were acutely depressed in these head-trauma patients and then gradually increased during the course of the study. This acute depression in the serum zinc level cannot be explained by increased losses in the urine, as is clear from the sequence of events in Figs. 1 and 2 . The depression of serum zinc concentration was most prominent on the I st study day, when urinary loss of zinc was the least apparent. On the other hand, at the end of the study period, serum zinc levels had increased to near the normal range, while urinary zinc excretion had substantially increased. Alterations in serum zinc. concentrations were similar in both enterally and parenterally fed groups, so the serum zinc response cannot be attributed to altered binding caused by intravenous amino acid administration. Serum zinc levels can decrease with any acute stress or inflammatory response. Studies in humans have demonstrated that adrenocorticotropin (ACTH) infusion can acutely depress the serum zinc level, and the recently described monokine, interleukin-l, has a similar effect, lz-ls C-reactive protein levels (which reflect the acute phase response) were elevated initially in the study and gradually declined, which supports the hypothesis that the acute hypozincemia TABLE 
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Urine zinc levels correlated with 24-hour peak GCS score*
Posttrauma
Zinc Levels (ug/day) The mechanism for the hyperzincuria in our patients and in patients with other catabolic disease states is not well defined. As noted previously, some degree of hyperzincuria is observed in a variety of disease processes. Renal handling of zinc appears to involve distal tubular reabsorption and, in some instances, proximal secretion. 2 It is unlikely that administration of mannitol to our patients caused major alterations in renal handling of zinc, as studies in dogs showed no major change in zinc clearance with mannitol administration. 2 Certain amino acids, such as cysteine and histidine, avidly bind zinc and cause zinc loss in the urine. 2' 6~' 65 Indeed, cysteine infusion in dogs causes marked hyperzincuria. 2'61'65 Alterations in serum binding of zinc, with more zinc being bound to low molecular weight proteins and amino acids being released during muscle catabolism, could help explain this hyperzincuria.
Study Day
Approximately 60% of total body zinc is found in muscle. Fell, et al., ~6 suggested that muscle catabolism and the acute phase response, with shifts in the binding of plasma zinc to lower molecular weight proteins and amino acids, may cause this hyperzincuria. These investigators administered zinc-65 to two patients prior to total hip replacement and then measured both labeled and cold urinary zinc levels after surgery. They reported a prominent pattern of increased urinary zinc excretion in their patients after surgery, quite similar to that observed in our head-trauma patients. These investigators suggested that the zinc losses originated from muscle catabolism, and that the urinary zinc determination may be a convenient additional index of the catabolic state.
Several metabolic functions vital to the recovery of head-trauma patients may be disrupted by zinc deficiency. The important role of zinc in normal protein and nucleic acid metabolism has been extensively studied. 59 Sandstead, et al., 49 have reported decreased brain size and reduced DNA, RNA, and protein content in rat pups born to zinc-deficient dams. Not only is there impaired protein production, but there is also increased protein catabolism in zinc-deficient rats. 49 In studies in man, we reported seven patients receiving total parenteral nutrition who developed severe zinc deficiency with acrodermatitis, and who had low levels of the visceral proteins albumin, transferrin, and prealbumin. 6 Depressed levels of all three proteins were improved or corrected with intravenous zinc supplementation alone.
Wolman, et al. ,63 evaluated the effects of differing levels of intravenous zinc supplementation in patients with gastrointestinal diseases receiving total parenteral nutrition. They demonstrated that positive zinc balance was associated with improved nitrogen retention. Their study suggested that zinc deficiency may impair the insulin response and the utilization of glucose and amino acids. This hypothesis, if correct, may partially explain the large negative nitrogen balances observed in the head-trauma patients reported here.
A corollary of this is the importance of zinc in wound healing. Pories, et a/., 46 stimulated interest in the role of zinc in wound healing with a report of enhanced healing of pilonidal cysts in subjects receiving zinc supplementation. Subsequent controlled studies by Hallb66k and Lanner 28 demonstrated improved wound healing of leg ulcers in patients whose serum zinc levels were low and who received oral zinc supplementation. Work by Sandstead, et al., 5~ clearly demonstrated impaired healing of excised and thermal burns in zinc-deficient compared to zinc-sufficient pair-fed control rats.
Zinc also plays an important role in immune function. Zinc-deficient animals have thymic and lymphnode atrophy and impaired cell-mediated cutaneous hypersensitivity. 9'7' 26 Lymphocytes isolated from zincdeficient animals demonstrate impaired response to phytohemagglutinin and depression of T cell-dependent antibody production? 9,25' 4~ We have reported two patients receiving total parenteral nutrition who developed severe zinc deficiency and a markedly depressed T cell response, as assessed by skin testing and T cell response to phytohemagglutinin stimulation. 3 Intravenous zinc supplementation alone corrected these defects. Previous studies from our group have also shown a high rate of anergy in head-trauma patients on the day of hospitalization. 48 Thus, anergy occurs before protein calorie malnutrition has developed in such patients. What role the low plasma zinc concentration or the release of mediators such as interleukin-1 has on immune function in these patients is currently being investigated.
Head trauma initiates complex structural and physiological derangements of the brain, which are undoubtedly affected by the patient's nutritional status before and after the injury. 8 Decreased serum zinc concentrations in our patients could alter cerebral zinc metabolism in several ways, which might affect the extent or rate of clinical recovery after severe brain injury. Zinc is enriched in the hippocampus, a structure involved in memory processing. Within the hippocampus, zinc is distributed coterminally in the mossy fibers where it is localized within synaptic vesicles and is considered likely to function, in some as yet undefined manner, in synaptic transmission. 2~ Recent evidence suggests that zinc may alter neuronal excitability by modifying the affinity of receptors for their transmitters. 53 Clearly, if cerebral zinc homeostasis is perturbed in our patients, widespread derangements of cerebral cortical activity could result and could be clinically manifested by seizures or alterations in consciousness. 35 Zinc is transported from the neuronal soma distally by slow axonal transport. 35 Although the physiological significance of this process is incompletely understood, it appears possible that zinc functions in the assembly of tubulin into microtubules. 23'3~ If this hypothesis is correct, then inhibition of this process by systemic zinc deficiency could directly inhibit repair of diffuse axonal damage by retarding movement of tubulin and/or assembly of this protein into microtubules. Although quite speculative, this mechanism is amenable to ex-perimental study, and could account for the protracted recovery of function that is clinically observed in many patients.
In summary, we report strikingly reduced serum zinc concentrations early in the post-injury course of headtrauma patients, and elevated urinary zinc losses that correlate with the severity of head injury later in the hospital course. Current recommendations for intravenous zinc supplementation are inadequate to replace urinary zinc losses in patients with more severe head injury. In conclusion, alterations in zinc status may play a role both in general and in specific brain metabolic alterations that occur in the head-trauma patient.
